SCHEMBL7185724

SCHEMBL7185724

CCCOc1ccc(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)c(OCCC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 4/20 0.62
CYP1B1 Q16678 4/20 0.62
DPP4 P27487 3/20 0.53
TNFRSF1A P19438 1/20 0.51
ABCG2 Q9UNQ0 2/20 0.51
ALDH1A1 P00352 2/20 0.48
RAB9A P51151 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
NPY1R P25929 1/20 0.48
NPY2R P49146 1/20 0.48
KMT2A Q03164 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PTPN1 P18031 1/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177347 0.95 CYP1A1 (0.57) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9113779 0.91 CYP1A1 (0.70) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7184981 0.88 CYP1A1 (0.61) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7184986 0.88 CYP1A1 (0.61) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9111707 0.88 CYP1A1 (0.67) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9115209 0.87 CYP1A1 (0.72) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9113474 0.87 CYP1A1 (0.66) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7191470 0.87 ABCG2 (0.67) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7185327 0.86 CYP1A1 (0.65) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9204757 0.86 MAPT (0.60) CYP1A1CYP1B1DPP4ABCG2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed